Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : LVIM049Z
Storage : -80℃ Shipping : Frozen on dry ice
Titer: Size:
| Cat. No. | LVIM049Z |
| Description | This lentivirus expresses human KRAS-G12V under the control of EF1a promoter. It also contains RFP reporter gene and blasticidin resistance gene for selection. This virus can be used for cell immortalization. |
| Gene | KRAS-G12V |
| Titer | Varies lot by lot, for example, ≥1*10^7 TU/mL, ≥1*10^8 TU/mL, ≥1*10^9 TU/mL etc. |
| Size | Varies lot by lot, for example, 100 ul, 500 ul, 1 mL etc. |
| Storage | Store at -80℃. Avoid multiple freeze/thaw cycles. |
| Shipping | Frozen on dry ice |
| Summary | Creative Biogene ensures high-quality lentivirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between lentivirus particle lots. |
| Mycoplasma | Creative Biogene routinely tests for mycoplasma contamination using a mycoplasma detection kit. Cell lines are maintained for approximately 20 passages before being discarded and replaced with a new vial of early passage cells. Approximately 2 weeks after thawing, cell culture supernatants are tested for mycoplasma contamination. Creative Biogene ensures that lentiviral products are free of mycoplasma contamination. |
| Purity | Creative Biogene evaluates the level of impurities, such as residual host cell DNA or proteins, in prepared lentiviral vectors to ensure they meet quality standards. |
| Sterility | The lentiviral samples were inoculated into cell culture medium for about 5 days and the growth of bacteria and fungi was tested. Creative Biogene ensures that the lentiviral products are free of microbial contamination. |
| Transducibility | Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of lentivirus to deliver genetic material into target cells, and assess gene expression and functional activities. |
| Proviral Identity Confirmation | All Creative Biogene lentiviral vectors are confirmed to have correctly integrated provirus using PCR. This test involves transducing cells with serial dilutions of the lentiviral vector, harvesting the cells a few days later, and isolating genomic DNA. This DNA is then used as a template to amplify a portion of the expected lentiviral insert. |
Lentiviral particles are replication-defective viral vectors derived from HIV-1, widely used for the efficient delivery of genetic material into mammalian cells, including both dividing and non-dividing cells. By leveraging the inherent ability of lentiviruses to integrate into the host genome, they enable stable, long-term expression of exogenous genes, making them the preferred tool for generating engineered cell lines, conducting gene overexpression or knockdown studies, and establishing disease models. The EF1a-hKRAS/G12V(RFP, Bla) lentiviral particles are a ready-to-use preparation that expresses the human oncogenic KRAS-G12V mutant under the control of the elongation factor 1α (EF1a) promoter. This vector also carries an RFP reporter gene and a blasticidin resistance gene, facilitating the tracking and selection of transduced cells.
This product is frequently employed in cancer research workflows that require sustained activation of the RAS-MAPK signaling pathway. Researchers use it to immortalize primary cells, introduce the G12V mutation into a normal cellular background, and investigate downstream effectors—such as RAF, MEK, and ERK—within the context of a transformed phenotype. The co-expressed RFP marker allows for the visual assessment of transduction efficiency via fluorescence microscopy or flow cytometry, while blasticidin selection aids in the establishment of cell lines that stably express KRAS-G12V. Furthermore, these lentiviral particles are suitable for developing in vivo xenograft or syngeneic tumor models, screening for inhibitors of the KRAS pathway, and validating the concept of "oncogene addiction" within isogenic cell systems.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Compared to other methods, this lentivirus streamlined our workflow. The RFP reporter allowed quick validation before selection.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.